Nalaganje...

Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program

Background. When combined with ceftazidime, the novel non–β-lactam β-lactamase inhibitor avibactam provides a carbapenem alternative against multidrug-resistant infections. Efficacy and safety of ceftazidime-avibactam plus metronidazole were compared with meropenem in 1066 men and women with complic...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Infect Dis
Main Authors: Mazuski, John E., Gasink, Leanne B., Armstrong, Jon, Broadhurst, Helen, Stone, Greg G., Rank, Douglas, Llorens, Lily, Newell, Paul, Pachl, Jan
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2016
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4872289/
https://ncbi.nlm.nih.gov/pubmed/26962078
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciw133
Oznake: Označite
Brez oznak, prvi označite!